MMP2 and columnar cell hyperplasia of the breast: IF was able to significantly reduce the CCH-induced increase of pro-MMP-2 levels at the cortex and cerebellum at the 15-day and 30-day time points, and at 30-day timepoint in the hippocampus (Fig. 5A-F).